Skip to main content
UniHealth

Doctor search

Vasu Divi, MD

Otolaryngology · Stanford

NPI 1750407334

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
18
4 carriers
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

18 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Divi’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

18 of 18 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A121464 · Current

Licensed to practise in California · since 2012 · expires 2028-01-31 · University of Michigan Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$172,232

Medicare paid this office $172,232 for 180 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Removal of lymph nodes, muscle, and tissue of neck18$21,546$1,197
Repair of wound by transferring skin, each additional 30.0 sq cm17$10,927$171
Repair of wound by transferring skin, 30.1-60.0 sq cm20$8,745$437
Partial thickness self skin graft to face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less16$6,747$422
New patient visit (45+ min)44$5,135$117
See all 12 services
Every Original Medicare service billed
Removal of lymph nodes, muscle, and tissue of neck18$21,546$1,197
Repair of wound by transferring skin, each additional 30.0 sq cm17$10,927$171
Repair of wound by transferring skin, 30.1-60.0 sq cm20$8,745$437
Partial thickness self skin graft to face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less16$6,747$422
New patient visit (45+ min)44$5,135$117
Short return visit (20+ min)74$4,508$54
Partial thickness self skin graft to trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less12$4,492$346
New patient visit (60+ min)19$3,086$162
Long return visit (40+ min)11$1,435$130
Return visit (30+ min)12$1,334$83
Short return visit (20+ min)13$1,149$88
Punch biopsy, first skin growth12$485$40

Procedures Medicare counted

Procedure volume Medicare published
Melanoma (skin cancer) excision24More than 77% of doctors who do this
Skin biopsy1-10None

Who their Medicare patients are

180 Original Medicare patients in 2024. Average age 77 · Women 34% · Also on Medicaid 14% · Health risk score 1.88. Sicker patients than 9 in 10 peers; the typical otolaryngology clinician is at 1.19.

Conditions among them: High blood pressure 69% · Coronary heart disease 34% · Chronic kidney disease 31% · Diabetes 25% · Atrial fibrillation 24% · Heart failure 18% · Cancer 18% · Depression 17% · COPD 14% · Stroke 9% · Dementia 7%.

The office billed $2,087,890, Medicare allowed $217,182 and paid $172,232; for 519 services of 84 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024180519771.88$2,087,890$172,232
2023166449771.70$1,705,390$149,093
2022136334751.63$1,181,701$121,151
2021151396741.64$1,174,350$130,984
2020125331751.91$1,133,347$122,055
2019165493751.98$1,384,223$158,083
2018143434751.73$1,027,185$127,417
2017111393742.05$1,057,995$114,854
2016122369742.23$906,931$104,631
2015107309742.39$756,498$86,412
201491350742.08$956,198$118,187
201376307741.72$750,214$100,719

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Removal of lymph nodes, muscle, and tissue of neck26$33,743$1,298
Repair of wound by transferring skin, 30.1-60.0 sq cm16$7,231$452
Short return visit (20+ min)85$6,184$56
New patient visit (45+ min)42$5,155$123
New patient visit (60+ min)17$2,839$167
Return visit (30+ min)13$1,174$90
Punch biopsy, first skin growth13$566$38

2022: 5 services

Original Medicare services billed in 2022
Removal of lymph nodes, muscle, and tissue of neck19$17,602$926
Short return visit (20+ min)64$4,205$57
New patient visit (45+ min)25$3,004$120
New patient visit (60+ min)14$2,362$169
Short return visit29$740$24

2021: 8 services

Original Medicare services billed in 2021
Skin graft with repair of small blood vessel12$27,640$1,974
Removal of lymph nodes, muscle, and tissue of neck12$12,205$1,017
Extensive removal of growth of face or scalp, 2.0 cm or more14$8,563$612
Short return visit (20+ min)77$5,998$54
New patient visit (45+ min)35$4,297$123
Partial thickness self skin graft to trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less11$3,770$343
New patient visit (30+ min)13$928$71
Short return visit32$880$27

2020: 6 services

Original Medicare services billed in 2020
Skin graft with repair of small blood vessel14$29,142$2,082
Removal of lymph nodes, muscle, and tissue of neck18$20,443$1,136
Short return visit (20+ min)68$3,304$40
New patient visit (60+ min)20$2,977$149
New patient visit (45+ min)12$1,443$120
Short return visit20$484$22

2019: 10 services

Original Medicare services billed in 2019
Removal of lymph nodes, muscle, and tissue of neck21$23,290$1,059
Skin graft with repair of small blood vessel12$20,553$1,713
Repair of wound by transferring skin, 30.1-60.0 sq cm11$5,355$487
Partial thickness self skin graft to trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less13$4,676$360
Short return visit (20+ min)73$4,167$40
New patient visit (45+ min)33$3,703$112
New patient visit (60+ min)13$1,980$152
Short return visit64$1,626$22
Return visit (30+ min)17$1,292$72
Diagnostic exam of voice box using a flexible endoscope15$854$53

2018: 7 services

Original Medicare services billed in 2018
Skin graft with repair of small blood vessel11$24,177$1,727
Removal of lymph nodes, muscle, and tissue of neck18$19,813$1,101
Short return visit (20+ min)89$6,680$43
New patient visit (45+ min)27$2,835$105
New patient visit (60+ min)14$2,016$144
Diagnostic exam of voice box using a flexible endoscope24$1,595$51
Return visit (30+ min)18$1,272$71

2017: 7 services

Original Medicare services billed in 2017
Removal of lymph nodes, muscle, and tissue of neck16$17,447$1,090
Extensive removal of growth of face or scalp, 2.0 cm or more11$7,904$659
Partial thickness self skin graft to face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less15$5,771$361
Short return visit (20+ min)77$5,386$40
New patient visit (45+ min)23$2,368$103
Diagnostic exam of voice box using a flexible endoscope22$1,721$57
Return visit (30+ min)11$585$53

2016: 6 services

Original Medicare services billed in 2016
Removal of lymph nodes, muscle, and tissue of neck13$18,166$1,397
Short return visit (20+ min)77$6,200$43
New patient visit (45+ min)21$2,333$111
New patient visit (60+ min)13$1,946$150
Diagnostic exam of voice box using a flexible endoscope18$1,397$67
Long return visit (40+ min)11$1,090$99

2015: 3 services

Original Medicare services billed in 2015
Extensive removal of growth of face or scalp, 2.0 cm or more13$8,824$679
Short return visit (20+ min)72$5,446$44
New patient visit (45+ min)18$1,963$109

2014: 7 services

Original Medicare services billed in 2014
Skin graft with repair of small blood vessel15$27,699$1,847
Removal of lymph nodes, muscle, and tissue of neck11$13,301$1,209
Extensive removal of growth of face or scalp, 2.0 cm or more11$7,466$622
Partial thickness self skin graft to trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less15$5,239$349
Short return visit (20+ min)61$4,827$41
New patient visit (45+ min)13$1,503$116
Diagnostic exam of voice box using a flexible endoscope11$1,207$60

2013: 5 services

Original Medicare services billed in 2013
Removal of lymph nodes, muscle, and tissue of neck11$11,489$1,044
Repair of wound by transferring skin, 30.1-60.0 sq cm11$5,954$496
Short return visit (20+ min)42$3,261$43
New patient visit (45+ min)21$2,375$113
Diagnostic exam of voice box using a flexible endoscope19$1,957$70

Money from drug and device companies

$20,705 in 2025

Industry payments by year
2025218$18,155$20,705
2024514$9,856$11,037
202314None$4,600
2022214$9,776$11,667
201911$2,520$2,520

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Regeneron Healthcare SolutionsLibtayo$18,774
17 payments
  • Consulting for Libtayo · 2025-05-30 · $832
  • Consulting for Libtayo · 2025-03-21 · $832
  • Consulting for Libtayo · 2025-03-21 · $6,656
  • Consulting for Libtayo · 2025-03-21 · $7,488
  • Travel for Libtayo · 2025-03-21 · $65
  • Travel for Libtayo · 2025-03-21 · $64
  • Consulting for Libtayo · 2025-03-07 · $416
  • Travel for Libtayo · 2025-02-26 · $495
  • Meals for Libtayo · 2025-02-26 · $41
  • Meals for Libtayo · 2025-02-26 · $108
  • Meals for Libtayo · 2025-02-26 · $51
  • Meals for Libtayo · 2025-02-26 · $46
  • Meals for Libtayo · 2025-02-26 · $106
  • Travel for Libtayo · 2025-02-18 · $253
  • Travel for Libtayo · 2025-02-18 · $161
  • Travel for Libtayo · 2025-01-14 · $1,003
  • Travel for Libtayo · 2025-01-14 · $160
Ethicon USVicryl$1,931
1 payment
  • Consulting for Vicryl · 2025-11-13 · $1,931
See all 18 published payments
Every published payment
Ethicon USConsulting · 2025-11-13Vicryl$1,931
Regeneron Healthcare SolutionsConsulting · 2025-05-30Libtayo$832
Regeneron Healthcare SolutionsConsulting · 2025-03-21Libtayo$832
Regeneron Healthcare SolutionsConsulting · 2025-03-21Libtayo$6,656
Regeneron Healthcare SolutionsConsulting · 2025-03-21Libtayo$7,488
Regeneron Healthcare SolutionsTravel · 2025-03-21Libtayo$65
Regeneron Healthcare SolutionsTravel · 2025-03-21Libtayo$64
Regeneron Healthcare SolutionsConsulting · 2025-03-07Libtayo$416
Regeneron Healthcare SolutionsTravel · 2025-02-26Libtayo$495
Regeneron Healthcare SolutionsMeals · 2025-02-26Libtayo$41
Regeneron Healthcare SolutionsMeals · 2025-02-26Libtayo$108
Regeneron Healthcare SolutionsMeals · 2025-02-26Libtayo$51
Regeneron Healthcare SolutionsMeals · 2025-02-26Libtayo$46
Regeneron Healthcare SolutionsMeals · 2025-02-26Libtayo$106
Regeneron Healthcare SolutionsTravel · 2025-02-18Libtayo$253
Regeneron Healthcare SolutionsTravel · 2025-02-18Libtayo$161
Regeneron Healthcare SolutionsTravel · 2025-01-14Libtayo$1,003
Regeneron Healthcare SolutionsTravel · 2025-01-14Libtayo$160
See earlier years (2024, 2023, 2022, 2019)

2024: $11,037

Payments by company in 2024
Regeneron PharmaceuticalsLibtayo$10,044
10 payments
  • Consulting for Libtayo · 2024-02-23 · $4,512
  • Consulting for Libtayo · 2024-02-23 · $4,512
  • Travel for Libtayo · 2024-02-23 · $72
  • Meals for Libtayo · 2024-01-10 · $39
  • Meals for Libtayo · 2024-01-10 · $98
  • Meals for Libtayo · 2024-01-10 · $134
  • Meals for Libtayo · 2024-01-10 · $113
  • Meals for Libtayo · 2024-01-10 · $54
  • Meals for Libtayo · 2024-01-10 · $49
  • Travel for Libtayo · 2024-01-10 · $461
Regeneron Healthcare SolutionsLibtayo$832
1 payment
  • Consulting for Libtayo · 2024-11-08 · $832
StrykerCore$73
1 payment
  • Meals for Core · 2024-08-15 · $73
SpringWorks TherapeuticsOgsiveo$47
1 payment
  • Meals for Ogsiveo · 2024-06-13 · $47
DePuy Synthes SalesTrumatch$41
1 payment
  • Meals for Trumatch · 2024-11-10 · $41

2023: $4,600

Payments by company in 2023
Regeneron PharmaceuticalsLibtayo$4,600
4 payments
  • Travel for Libtayo · 2023-11-20 · $189
  • Travel for Libtayo · 2023-11-20 · $155
  • Travel for Libtayo · 2023-11-03 · $4,221
  • Travel for Libtayo · 2023-11-03 · $35

2022: $11,667

Payments by company in 2022
Regeneron PharmaceuticalsLibtayo$11,399
12 payments
  • Consulting for Libtayo · 2022-12-23 · $4,512
  • Consulting for Libtayo · 2022-12-23 · $752
  • Consulting for Libtayo · 2022-12-23 · $4,512
  • Meals for Libtayo · 2022-11-30 · $38
  • Meals for Libtayo · 2022-11-30 · $102
  • Meals for Libtayo · 2022-11-30 · $26
  • Travel for Libtayo · 2022-11-30 · $315
  • Meals for Libtayo · 2022-11-30 · $150
  • Meals for Libtayo · 2022-11-30 · $80
  • Meals for Libtayo · 2022-11-30 · $44
  • Travel for Libtayo · 2022-11-07 · $831
  • Travel for Libtayo · 2022-11-07 · $35
Baxter HealthcareNone$268
2 payments
  • Meals · 2022-12-09 · $144
  • Meals · 2022-09-12 · $124

2019: $2,520

Payments by company in 2019
Regeneron PharmaceuticalsLibtayo$2,520
1 payment
  • Consulting for Libtayo · 2019-05-01 · $2,520

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Regeneron Pharmaceuticals, Inc. · A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II To IV (M0) Cutaneous Squamous Cell Carcinoma (Cscc) · 2023Their institution$365,903
Regeneron Pharmaceuticals, Inc. · A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II To IV (M0) Cutaneous Squamous Cell Carcinoma (Cscc) · 2021Their institution$212,780
Genentech, Inc. · Neoadjuvant Atezolizumab for Advanced Cutaneous Scc · 2023Their institution$171,524
Regeneron Pharmaceuticals, Inc. · A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma · 2024Their institution$166,620
Genentech, Inc. · Neoadjuvant Atezolizumab for Advanced Cutaneous Scc · 2024Their institution$152,950
Regeneron Pharmaceuticals, Inc. · A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II To IV (M0) Cutaneous Squamous Cell Carcinoma (Cscc) · 2022Their institution$115,766
Regeneron Pharmaceuticals, Inc. · A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma · 2025Their institution$89,603
Merck Sharp & Dohme LLC · A Phase 2,3, Adaptive, Randomized, Open-Label, Clinical Study To Evaluate Neoadjuvant and Adjuvant V940 Mrna-4157 in Combination With Pembrolizumab Mk-3475 Versus Standard of Care, and Pembrolizumab Monotherapy in Participants With Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma La Cscc Interpath-007 · 2024Their institution$66,420
Regeneron Pharmaceuticals, Inc. · A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II To IV (M0) Cutaneous Squamous Cell Carcinoma (Cscc) · 2024Their institution$58,338
Regeneron Pharmaceuticals, Inc. · A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II To IV (M0) Cutaneous Squamous Cell Carcinoma (Cscc) · 2025Their institution$53,230
Genentech, Inc. · Neoadjuvant Atezolizumab for Advanced Cutaneous Scc · 2022Their institution$30,315
Genentech, Inc. · Neoadjuvant Atezolizumab for Advanced Cutaneous Scc · 2021Their institution$13,184
Regeneron Pharmaceuticals, Inc. · Libtayo Clinical Publication Program · 2022This clinician$2,126
Regeneron Pharmaceuticals, Inc. · Libtayo Clinical Publication Program · 2024This clinician$559
Regeneron Pharmaceuticals, Inc. · Libtayo Clinical Publication Program · 2023This clinician$536
Regeneron Pharmaceuticals, Inc. · Libtayo Clinical Publication Program · 2025This clinician$192

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1750407334
Licence
CA A121464, MI 4301083303California A121464: Current · expires 2028-01-31
Trained
University of Michigan Medical School, 2004
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207YX0905X (207YX0905X); Otolaryngology (207Y00000X); Student in a training program (390200000X)
Mailing address
1804 Embarcadero Rd, Ste 100, Palo Alto, CA, 94303
NPI first listed
2007-03-22
NPI last updated
2024-04-28
NPI record certified
2024-04-28

This is when the NPI record was last certified, not a medical board exam.